Ricky W. Johnstone
Molecular Biology · 2002–2014
A researcher in the Science corpus: 7 papers; trusts 19 researchers and is trusted by 22 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 159 citations into it; #1,989 of 17,773 by trust here, #3,866 by citations
- Oncology — 51 citations into it; #951 of 1,698 by trust here, #852 by citations
- Immunology — 26 citations into it
- Cancer Research — 19 citations into it
Whom Ricky W. Johnstone trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Keith D. Robertson
- Douglas R. Green
- PA Marks
- Manel Esteller
- D. Hanahan
- James E. Bradner
- T. Jenuwein
- A. Baldwin
- K. Ryan
- A. Ashkenazi
Who trusts Ricky W. Johnstone overall
- Marcy J. Balunas
- A. Kinghorn
- Peter W. Laird
- Madhusoodanan Mottamal
- D. Trachootham
- Jessica E. Bolden
- S. Ropero
- S. Minucci
- Suzanne Cory
- K. Falkenberg
Papers from Ricky W. Johnstone's perspective
Ordered by how strongly the researchers Ricky W. Johnstone trusts endorse each paper. Same corpus, a different order for every researcher.
- Anticancer activities of histone deacetylase inhibitors (Nature reviews. Drug discovery)
- Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death (Science)
- Targeting death and decoy receptors of the tumour-necrosis factor superfamily (Nature Reviews. Cancer)
- Deacetylation of p53 modulates its effect on cell growth and apoptosis (Nature)
- Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase (Nature)
- Promoting apoptosis as a strategy for cancer drug discovery (Nature Reviews. Cancer)
- Translating the Histone Code (Science)
- Inactivation of the apoptosis effector Apaf-1 in malignant melanoma (Nature)
- Life in the balance: how BH3-only proteins induce apoptosis. (Current Opinion in Cell Biology)
- The Hallmarks of Cancer Review
Their papers
- Anticancer activities of histone deacetylase inhibitors (2006) — 2,938 citations
- Apoptosis A Link between Cancer Genetics and Chemotherapy (2002) — 2,368 citations
- Histone-deacetylase inhibitors: novel drugs for the treatment of cancer (2002) — 1,513 citations
- Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders (2014) — 1,453 citations
- Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis (2007) — 663 citations
- The TRAIL apoptotic pathway in cancer onset, progression and therapy (2008) — 853 citations
- New and emerging HDAC inhibitors for cancer treatment. (2014) — 1,280 citations